| FNGR 0.398 129.53% | CHAI 0.4 57.11% | LGCL 0.0389 -27.02% | CYAB 0.4467 45.36% | NVDA 217.55 -4.57% | CHGA 2.852 2,082.10% | PCG 16.6 -7.52% | NCPL 0.6916 28.41% | NVD 4.05 8.58% | BITO 10.45 -3.06% | IREN 35.45 -12.53% | INTC 89.47 -2.85% | NU 14.3 -3.90% | IBIT 43.9 -3.07% | XTNT 0.384 16.36% | TSLL 8.98 -3.54% | ONDS 7.9 -9.71% | DUO 0.9602 37.56% | AAL 13.64 -0.58% | SOAR 0.2169 5.80% | SOXL 111.34 -9.52% | BTAI 0.1814 -74.76% | TQQQ 71.85 -1.98% | ETHA 18.37 -2.65% | FTFT 2.2188 281.50% | SPCX 141.5 0.45% | PATH 18.15 -0.98% | BMNR 23.8 -7.14% | NOK 10.21 -3.59% | AMZN 266.43 3.97% | MRVL 216.62 -10.28% | SOXS 49.82 9.86% | WHLR 1.07 -4.46% | SQQQ 38.54 2.03% | PLUG 2.19 -3.52% | SOFI 18.06 -5.84% | AEMD 2.49 14.75% | SPDN 8.49 0.12% | QID 14.24 1.42% | MARA 10.67 -10.11% | KEEL 3.23 -7.98% | GDX 99.65 -3.90% | RIVN 16.07 -4.35% | F 13.87 -0.57% | BTG 5.66 -2.92% | AAPL 319.7 1.63% | PURR 11.61 -9.51% | SMR 9.29 -4.62% | VALE 15.03 -1.83% | SPY 769.35 -0.23%

Recent Market Trends Highlight Top Gainers

In recent market trends, several companies have emerged as top gainers, showcasing significant price movements and trading volumes. AMTD Digital Inc. (NYSE:HKD) leads with a 93.49% price increase to $3.27, driven by a trading volume of approximately 286.36 million. This surge is supported by a remarkable 1,085.9% revenue increase for the six months ending April 30, 2025, following the consolidation of The Generation Essentials Group as a subsidiary since October 2024, as highlighted by the company.

Beneficient (NASDAQ:BENF) experienced a 57.18% increase in its stock price to $0.87, with a trading volume of over 113.62 million. The company has regained compliance with Nasdaq's periodic filing and market value requirements, which may have contributed to the heightened investor interest. However, Beneficient still needs to address the $1.00 per share bid price requirement to avoid delisting.

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) saw a 50.69% increase in its stock price to $2.18, with a trading volume of over 31.48 million. The company is set to present preclinical data on its innovative RaniPill® capsule at ObesityWeek® 2025, which may have fueled investor interest in its innovative healthcare solutions.

YD Bio Limited Warrants (YDESW) experienced a 47.06% increase in its stock price to $1.5, despite a smaller trading volume of 22,699. The company's focus on detection and therapeutic technologies has shown promising growth potential, attracting investor attention.

These movements reflect a dynamic market environment, with investors showing keen interest in companies across various sectors. The significant price changes and trading volumes highlight the market's responsiveness to company developments, investor sentiment, and broader economic factors.

Published on: October 31, 2025